)
Narinder (Nani) Bhalla, MD
Chief Medical Officer
Lexeo Therapeutics, Inc.
Narinder (Nani) is a physician-executive with more than 20 years of experience as an interventional cardiologist and nearly a decade of leadership in the biopharmaceutical industry. Since transitioning to industry in 2015, he has held senior leadership roles at Bristol Myers Squibb and AstraZeneca, most recently serving as Bristol Myers Squibb’s Senior Vice President and Head of Global Medical, Immunology & Cardiovascular. Nani holds an MD from the University of Buffalo. He completed his residency and cardiology fellowship at New York University Medical Center, as well as interventional training at Mount Sinai Medical Center. Nani is currently the Chief Medical Officer at Lexeo Therapeutics, Inc.
Sessions
-
24-Jun-2026Theater 3Lexeo Therapeutics, Inc.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}